State Street Corp Prelude Therapeutics Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, State Street Corp holds 286,046 shares of PRLD stock, worth $260,301. This represents 0.0% of its overall portfolio holdings.

Number of Shares

286,046

Previous 211,746 35.09%

Holding current value

$260,301

Previous $806,000 26.55%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.07 - $6.37 $153,801 - $473,291	74,300 Added 35.09%	286,046 $592,000
Q2 2024 Aug 14, 2024	BUY	$3.32 - $5.63 $1,012 - $1,717	305 Added 0.14%	211,746 $806,000
Q1 2024 May 15, 2024	SELL	$2.68 - $4.84 $2,125 - $3,838	-793 Reduced 0.37%	211,441 $1 Million
Q4 2023 Feb 14, 2024	BUY	$1.69 - $4.37 $42,292 - $109,359	25,025 Added 13.37%	212,234 $906,000
Q3 2023 Nov 14, 2023	BUY	$2.74 - $4.79 $9,316 - $16,286	3,400 Added 1.85%	187,209 $578,000
Q2 2023 Aug 14, 2023	BUY	$4.45 - $8.12 $622,644 - $1.14 Million	139,920 Added 318.8%	183,809 $827,000
Q2 2022 Aug 15, 2022	SELL	$4.0 - $7.55 $663,888 - $1.25 Million	-165,972 Reduced 79.09%	43,889 $229,000
Q1 2022 May 16, 2022	BUY	$6.9 - $13.22 $10,039 - $19,235	1,455 Added 0.7%	209,861 $1.45 Million
Q4 2021 Feb 14, 2022	SELL	$11.89 - $31.74 $7.63 Million - $20.4 Million	-642,077 Reduced 75.5%	208,406 $2.6 Million
Q3 2021 Nov 15, 2021	SELL	$25.78 - $38.65 $5.2 Million - $7.8 Million	-201,733 Reduced 19.17%	850,483 $26.6 Million
Q2 2021 Aug 16, 2021	BUY	$28.63 - $44.3 $5.12 Million - $7.92 Million	178,840 Added 20.48%	1,052,216 $30.1 Million
Q1 2021 May 17, 2021	BUY	$39.27 - $91.68 $28.7 Million - $67 Million	731,043 Added 513.61%	873,376 $37.8 Million
Q4 2020 Feb 16, 2021	BUY	$28.81 - $88.94 $4.1 Million - $12.7 Million	142,333 New	142,333 $10.2 Million

Others Institutions Holding PRLD

# of Institutions

Shares Held

35.7M

Call Options Held

500

Put Options Held

300

View Full List

About Prelude Therapeutics Inc

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $33.1M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

More about PRLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Prelude Therapeutics Inc Transaction History